US Government's NIH Awards Millions to Continue Funding Feline Experiments Despite Promises to Phase Out, Watchdog Says
In a stunning contradiction, the US National Institutes of Health (NIH) has continued to fund new laboratory experiments on cats, despite announcing earlier this year that it would "phase out" such projects. Documents obtained by White Coat Waste, a watchdog campaigning to end taxpayer-funded animal experiments, reveal that the NIH has awarded over $1.7 million in new and extended grants for experiments using cats since July.
The NIH's assertion that it is constrained under the law from ending existing grants is disputed by the organization itself, which states there is "no legal obligation to provide funding beyond the ending date of the current budget period". The NIH has also emphasized its commitment to prioritizing human-based research and reducing reliance on animal models. However, recent funding decisions appear to contradict these claims.
One such example is a $486,000 grant for a study investigating blood flow in the brain after stroke, which involves removing portions of kittens' skulls, injecting viruses into their brains, paralyzing them, and inducing strokes before killing them. Another grant of $439,000 was awarded for a study examining gene therapy for human glaucoma, which includes injecting viruses into the eyes of three-month-old "mutant" kittens bred with glaucoma.
The watchdog group White Coat Waste is calling on the NIH to cancel all existing grants for cat testing and prohibit new ones. Senior vice-president Justin Goodman said that the organization has exposed how the NIH is "doubling down" on funding animal experiments, despite being misled by the Director's Desk podcast where Dr Nicole Kleinstreuer announced a shift towards phasing out such projects.
The issue highlights the growing federal effort to reduce animal use in US laboratories. This April, the FDA Modernization Act 2.0 removed the requirement for animal testing before human trials, and this year, Congress directed veteran affairs to end research on dogs, cats, and primates by 2026.
However, despite these efforts, many critics argue that animal studies remain essential in biomedical research and drug development. The National Association for Biomedical Research has stated that "there is currently no full replacement for animal models" and called for legislative and agency actions to accelerate the trend of reducing animal use.
In a related development, Democratic congresswoman Dina Titus co-sponsored the PAAW Act, which would prohibit NIH-funded research that causes "significant pain or distress" to dogs or cats. If passed, it would be a significant step towards curbing animal testing in US laboratories.
In a stunning contradiction, the US National Institutes of Health (NIH) has continued to fund new laboratory experiments on cats, despite announcing earlier this year that it would "phase out" such projects. Documents obtained by White Coat Waste, a watchdog campaigning to end taxpayer-funded animal experiments, reveal that the NIH has awarded over $1.7 million in new and extended grants for experiments using cats since July.
The NIH's assertion that it is constrained under the law from ending existing grants is disputed by the organization itself, which states there is "no legal obligation to provide funding beyond the ending date of the current budget period". The NIH has also emphasized its commitment to prioritizing human-based research and reducing reliance on animal models. However, recent funding decisions appear to contradict these claims.
One such example is a $486,000 grant for a study investigating blood flow in the brain after stroke, which involves removing portions of kittens' skulls, injecting viruses into their brains, paralyzing them, and inducing strokes before killing them. Another grant of $439,000 was awarded for a study examining gene therapy for human glaucoma, which includes injecting viruses into the eyes of three-month-old "mutant" kittens bred with glaucoma.
The watchdog group White Coat Waste is calling on the NIH to cancel all existing grants for cat testing and prohibit new ones. Senior vice-president Justin Goodman said that the organization has exposed how the NIH is "doubling down" on funding animal experiments, despite being misled by the Director's Desk podcast where Dr Nicole Kleinstreuer announced a shift towards phasing out such projects.
The issue highlights the growing federal effort to reduce animal use in US laboratories. This April, the FDA Modernization Act 2.0 removed the requirement for animal testing before human trials, and this year, Congress directed veteran affairs to end research on dogs, cats, and primates by 2026.
However, despite these efforts, many critics argue that animal studies remain essential in biomedical research and drug development. The National Association for Biomedical Research has stated that "there is currently no full replacement for animal models" and called for legislative and agency actions to accelerate the trend of reducing animal use.
In a related development, Democratic congresswoman Dina Titus co-sponsored the PAAW Act, which would prohibit NIH-funded research that causes "significant pain or distress" to dogs or cats. If passed, it would be a significant step towards curbing animal testing in US laboratories.